DRUG REPURPOSING IN THE ERA OF COVID-19.

Abstract

Corona virus infections have spread widely to affect tens of millions. The very limited time allowed to face the COVID-19 pandemic poses a pressing challenge to find proper therapeutic approaches. Efforts made to identify commercially available drugs in order to repurpose them against coronavirus will be highlighted in this talk. Different and integrating strategies for repurposing will be identified and explained, including: the multitude of potential targets on the pathogen (SARS-CoV2), as well as effector targets on the human host, and Computer Aided Drug Design made for a tsunami of drug repurposing projects. Among the discussed repurposed classes are: antiparasitic, antibiotics, antivirals, and immunological.